Khalid Shah

24PUBLICATIONS
67CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMolecular targetsNanometrologyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Feb 20, 2026
Repurposing Tumor Cells: A Paradigm Shift in Cell-Based Therapies for Cancer.

Kok-Siong Chen, Laura Y Lin, Yi-Ching Chen

|Jun 12, 2025
Author Correction: Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types.

Jasneet Kaur Khalsa, Nina Cheng, Joshua Keegan

|Apr 16, 2025
Antitumor Immunity Mediated by Engineered Stem Cells Exploiting TRAIL-Induced Cell Death and FLT3L Immunomodulation.

Thijs A van Schaik, Kok-Siong Chen, Nobuhiko Kanaya

|Mar 22, 2025
Retraction Note: Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells.

Deepak Bhere, Sung Hugh Choi, Pim van de Donk

|Sep 23, 2024
A zwitterionic twist.

Sihan Xiong, Khalid Shah, Chuang Liu

|Jul 23, 2024
Editorial Expression of Concern: Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization.

Ahmet Cingöz, Ezgi Ozyerli-Goknar, Tunc Morova

Pageof 4

Frequent Collaborators

8 joint publications

Deepak Bhere

5 joint publications

Hiroaki Wakimoto

4 joint publications

Kok-Siong Chen

4 joint publications

Clemens Reinshagen